This Season’s Flu Vaccines Reduced Medical Visits, Hospitalizations

["Centers for Disease Control and Prevention" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

Early estimates show that so far this flu season, flu vaccines provided substantial protection against flu medical visits and hospitalizations across all age groups.

March 1, 2024

	Influenza (Flu) 2023 - 2024 Flu Season

www.cdc.gov/flu

Weekly U.S. Influenza Surveillance Report Seasonal influenza activity remains elevated nationally, with increases in some parts of the country. Two flu-related deaths in children were reported this week, bringing the total reported this season to 93. CDC continues to recommend flu vaccination at this time.

Learn More

	Expanding Viral Genomic Sequencing Infrastructure in the U.S. Knowing what flu viruses are circulating and where is critical to public health decision-making and pandemic preparedness. In cooperation with the Association for Public Health Laboratories, CDC supports a network of state labs with funding and training to rapidly and accurately sequence influenza viruses. Learn More

This Season’s Flu Vaccines Reduced Medical Visits, Hospitalizations Across All Age Groups Early estimates show that so far this flu season, flu vaccines provided substantial protection against flu medical visits and hospitalizations across all age groups. Data from four flu surveillance networks show that for children, flu vaccines reduced the risk of flu medical visits by about two-thirds and flu-related hospitalizations by about half. For adults, flu vaccines reduced the risk of flu medical visits by half and hospitalizations by about 40%. Learn More

	X @CDCFlu Interim data shows that #flu vaccination in children provided substantial protection against flu-related outcomes so far this season. An annual #FluVax is important for children. Learn more about the 2023-2024 flu vaccine effectiveness estimates: https://bit.ly/42X3sk2

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |